<DOC>
	<DOCNO>NCT01212809</DOCNO>
	<brief_summary>This study do evaluate difference performance two well know injectable dermal filler commonly use cosmetic treatment age line lips cheek compare patient . The product test Juvéderm® Ultra CosmoDerm® 1 .</brief_summary>
	<brief_title>Comparative Study Reconstituted JUVÉDERM® Ultra v COSMODERM® 1 Lip Cheek Lines , Folds Wrinkles</brief_title>
	<detailed_description>This single center , prospective , open label , randomize , comparative , split-face study adult female male age 25 70 year seek treatment reconstitute Juvéderm® Ultra CosmoDerm® 1 human-based collagen implant moderate severe vertical lip rhytids and/or radial cheek line .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Adult female male , age 25 70 year ; Subjects must seek treatment Juvéderm Ultra CosmoDerm 1 injection vertical lip rhytids radial cheek line ; Subjects must one moderate severe vertical lip rhytids and/or moderate severe radial cheek line base physician evaluator assessment ( 03 scale ) ; Women must either nonchildbearing potential ( i.e. , surgically sterilize postmenopausal ) childbearing potential , must pregnant ( document negative urine pregnancy test baseline examination ) lactating must practice medically acceptable method birth control ; Subjects must willing able provide write informed consent ; Subjects must willing able follow procedure outline protocol . Female subject pregnant ( positive urine pregnancy test ) infant breastfeed childbearing potential practicing reliable method birth control ; Previous Botox treatment low twothirds face within past 6 month subject injection radial cheek line . Note : exclusion criterion apply subject injection lip rhytids unless previous Botox treatment administer within past 6 month upper lip region ; Previous semipermanent injectable filler therapy midlower face within past year prior history permanent filler therapy injection midlower face ; Prior cosmetic procedure ( i.e. , facelift , etc . ) visible scar may affect evaluation response and/or quality photography opinion investigator ; Known allergy sensitivity treatment injection component , include know suspected lidocaine hypersensitivity ; Known severe allergy manifest history anaphylaxis history presence multiple severe allergy ; Subjects infection injection site systemic infection ( case , postpone study entry one week follow recovery ) ; Subjects require treatment major anticoagulant ( Coumadin ) antiplatelets ( Plavix ) study ; lowdose aspirin treatment antiinflammatory medication potential anticoagulant antiplatelet effect may allow investigator 's discretion ; Concurrent participation investigational drug device study participation within 30 day study start ; Subjects undergo additional cosmetic procedure study period ; Subjects change use facial product 6 month prior enrollment study period ; Subjects history poor cooperation , noncompliance medical treatment , unreliability .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>